TNNT2 and myocarditis: In this case, cTnT elevation was first detected on routine troponin testing performed because myocarditis is a recognized immune-related adverse event of nivolumab, despite the absence of typical cardiac symptoms.<h4>Case summary</h4>A 72-year-old man receiving nivolumab developed marked cTnT elevation.